Flatiron Health
Real-world oncology data + AI to accelerate cancer insights and decisions.
Flatiron is the definitive source for oncology real-world evidence, backed by deep data curation and a strong publication track record. The launch of Flatiron Telescope brings AI speed, but the enterprise pricing narrows its audience to well-funded life science teams.
- Life sciences companies generating real-world evidence for regulatory submissions
- Oncology researchers needing large-scale, high-fidelity patient data for biomarker and outcomes analysis
- Biopharma firms using AI-driven insights to accelerate clinical trial design and patient selection
- Healthcare providers seeking point-of-care tools integrated with real-world data for treatment decisions
- Early-stage startups with limited budget for enterprise data partnerships
- Researchers needing real-world data beyond oncology (e.g., cardiology, neurology)
- Teams requiring rapid, self-service analytics without vendor support
We scan live Reddit threads, YouTube comments, X posts, G2 reviews and other communities — and hand you an honest verdict in under a minute.
- Honest verdict, not marketing
- Real pros & cons from real users
- Attributed quotes with receipts
3 free scans · no card needed
Skip Flatiron Health if you are a startup or individual researcher needing affordable, self-service access to real-world data outside oncology.
Custom pricing means costs can escalate quickly depending on data volume and study complexity.
Flatiron Health's pricing is custom and enterprise-level, making it best for large biopharma firms with dedicated RWE budgets. For smaller organizations, alternatives like COTA or Syapse may offer more accessible pricing.
In short
Flatiron Health — Real-world oncology data + AI to accelerate cancer insights and decisions. Best for Life sciences companies generating real-world evidence for regulatory submissions, Oncology researchers needing large-scale, high-fidelity patient data for biomarker and outcomes analysis, Biopharma firms using AI-driven insights to accelerate clinical trial design and patient selection. Contact Sales pricing.
Viability Score
How likely is Flatiron Health to still be operational in 12 months? Based on 4 signals — momentum (how recently it shipped), wrapper dependency, revenue model, and web presence.
Last calculated: July 2026
How we score →Key Features
- Real-world data from millions of oncology patients globally
- Flatiron Telescope AI platform for rapid oncology insights
- LLM-based thematic analysis of clinical trial discussions
- ML models predicting rapid progression in HR+/HER2- metastatic breast cancer
- Real-world biomarker testing and outcomes studies
- Point-of-care clinical decision support
- Regulatory-grade real-world evidence generation
- Cancer-specific data abstraction and curation
- Custom study design and analytics services
- Data quality assurance and validation processes
- Multi-cancer type cohort identification
- Publication support – over 2,000 peer-reviewed papers
- 49+ research acceptances at ASCO 2026
- Integration with life sciences workflows
- Professional services for research collaborations
About Flatiron Health
Flatiron Health combines high-fidelity real-world oncology data with AI powered by human expertise to answer cancer's hardest questions. Serving life sciences researchers and point-of-care clinicians, the platform captures data from millions of patients globally and transforms it into regulatory-grade evidence. Key capabilities include Flatiron Telescope – a new AI platform delivering insights in minutes – as well as LLM-based thematic analysis of clinical trial discussions, ML models predicting rapid progression in HR+/HER2- metastatic breast cancer, and real-world biomarker testing studies. With over 2,000 publications and 49+ research acceptances at ASCO 2026, Flatiron's oncology-specific depth and human-in-the-loop AI set it apart for mission-critical cancer research. While its enterprise focus and likely high cost limit accessibility, for organizations needing validated real-world evidence under regulatory scrutiny, Flatiron is the benchmark.
Behind the Verdict
We'd reach for Flatiron Health when the stakes involve regulatory submissions, publication-grade evidence, or clinical trials where data quality is non-negotiable. Its oncology-specific data – captured from millions of patients – is a moat that general health data platforms can't easily replicate. The newly launched Flatiron Telescope promises to cut insight generation from months to minutes, a significant leap. But where it bites is pricing: this is enterprise-only, with no self-service tier or public price list. Smaller biotechs or academic groups will find the cost prohibitive. Compared to other real-world evidence players like IQVIA or Syapse, Flatiron leans more heavily on proprietary AI (LLM analysis, ML predictions) while keeping human curation in the loop. The tool is best for large pharma, CROs, and regulatory researchers – not for exploratory early-stage work or non-oncology diseases.
Researching Flatiron Health? Get your full AI stack in 60 seconds.
Free, no signup — tell us your goal and get tools matched to your budget & existing stack.
Real-world workflow fit
Concrete scenarios for the personas Flatiron Health actually fits — and what changes day-one when you adopt it.
Designing an observational study for a new breast cancer therapy
Outcome: Using Flatiron's ML models and RWD, the researcher identifies patient cohorts and analyzes real-world outcomes, generating evidence for regulatory submission.
Needing up-to-date treatment guidelines at the point of care
Outcome: Flatiron's point-of-care solution provides guideline-concordant regimens and patient-specific insights, improving treatment decisions.
Assessing feasibility of a clinical trial in advanced gastric cancer
Outcome: Using Flatiron Telescope, the biostatistician explores real-world patient data and identifies eligible sites in minutes, accelerating trial startup.
Use Cases
- Analyze real-world treatment patterns and outcomes for 5M+ de-identified oncology patients.
- Generate regulatory-grade real-world evidence for label expansion or post-marketing requirements.
- Provide clinicians with up-to-date treatment guidelines and customizable regimens at the point of care.
- Assess study feasibility and size opportunity in minutes using Flatiron Telescope AI platform.
- Conduct large language model-based thematic analysis of clinical trial discussions for real-world adoption.
Models Under the Hood
as of 2026-07-06
Limitations
- Flatiron Health is a B2B platform with no self-service or free tier.
- Pricing is custom and likely high-cost.
- Access to full data and AI capabilities requires partnership agreements.
- Product documentation and tutorials are not publicly available.
as of 2026-06-30
Where the pricing makes sense
The company stage and team size where Flatiron Health's pricing actually pencils out — and where peers do it cheaper.
Flatiron Health's pricing is custom and enterprise-level, making it best for large biopharma firms with dedicated RWE budgets. For smaller organizations, alternatives like COTA or Syapse may offer more accessible pricing.
Setup time & first value
How long it actually takes to get something useful out of Flatiron Health — broken out by persona, not the marketing-page minute.
For life sciences, initial data access and study setup can take several weeks due to legal and data integration agreements. Point-of-care deployment may be faster, typically weeks after partnership execution. Flatiron Telescope AI platform can provide initial insights within minutes after data access is granted.
Switching to or from Flatiron Health
How to bring data in from common predecessors and how to get it back out — written for the switcher, not the buyer.
- ↗To COTA: Migrate custom study definitions and cohort queries to COTA's platform via API or manual mapping.
- ↗To Syapse: Export patient-level data和分析 results in standard formats (CSV, FHIR) for import into Syapse.
Integrations
Resources & Guides
Official links
Tools that pair well with Flatiron Health
Common stack mates teams adopt alongside Flatiron Health, with the specific reason each pairing earns its keep.
Alternatives to Flatiron Health
View allTempus
AI-powered precision oncology platform analyzing clinical and molecular data for personalized cancer care.
Recursion
AI-driven drug discovery platform using phenomics and massive biological datasets
Nimbus Therapeutics
AI-driven small molecule drug discovery for selective oncology and immunology
Frequently Asked Questions
Categories
Topics
Used Flatiron Health? Help shape our editorial sentiment research.